Brusselaers, who began his career as a diplomat in the Middle East, is considered one of the health tech world’s sharpest thinkers in the realm of AI. That’s reflected in his work at Deep 6 AI, a ...
Tempus AI, Inc. TEM recently announced the acquisition of Deep 6 AI, a leading artificial intelligence (AI) company specializing in clinical trial matching. This strategic move aims to enhance Tempus’ ...
Deep 6 AI, its directors including CEO and controlling shareholder Wout Brusselaers and Tempus AI were sued on Dec. 9 in Delaware Court of Chancery following an alleged unfair merger with Tempus AI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results